Consider Our Overview Before Taking a Position in WELL

Large-cap Real Estate company Welltower has logged a 0.6% change today on a trading volume of 809,396. The average volume for the stock is 2,080,988.

Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Based in Toledo, United States the company has 514 full time employees and a market cap of $43,718,479,872. Welltower currently offers its equity investors a dividend that yields 2.9% per year.

The company is now trading -4.91% away from its average analyst target price of $88.63 per share. The 16 analysts following the stock have set target prices ranging from $78.0 to $96.0, and on average give Welltower a rating of buy.

Over the last 52 weeks, WELL stock has risen 14.0%, which amounts to a -1.0% difference compared to the S&P 500. The stock's 52 week high is $86.39 whereas its 52 week low is $56.5 per share. With its net margins declining an average -23.5% over the last 6 years, Welltower may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023-02-21 5,860,615 141,214 2 -71.43
2022-02-16 4,742,115 336,138 7 -66.67
2021-02-10 4,605,967 978,844 21 -12.5
2020-02-14 5,121,306 1,232,432 24 41.18
2019-02-25 4,700,499 804,954 17 41.67
2018-02-28 4,316,641 522,774 12
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.